Bhattacharjee et al., 2002 - Google Patents
Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis …Bhattacharjee et al., 2002
View PDF- Document ID
- 12814369856409386822
- Author
- Bhattacharjee A
- Van De Verg L
- Izadjoo M
- Yuan L
- Hadfield T
- Zollinger W
- Hoover D
- Publication year
- Publication venue
- Infection and immunity
External Links
Snippet
Intranasal immunization of mice with purified Brucella melitensis lipopolysaccharide (LPS) as a noncovalent complex with Neisseria meningitidis group B outer membrane protein (GBOMP) elicited a high-titer anti-LPS systemic antibody response and a significant mucosal …
- 239000002158 endotoxin 0 title abstract description 61
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Svennerholm et al. | Recent progress toward an enterotoxigenic Escherichia coli vaccine | |
| Secundino et al. | Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response | |
| Bhattacharjee et al. | Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein | |
| García et al. | The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers | |
| Hagan et al. | Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection | |
| Perry et al. | Yersinia pestis--etiologic agent of plague | |
| Hatcher et al. | Recent advances in Burkholderia mallei and B. pseudomallei research | |
| Fulop et al. | Role of antibody to lipopolysaccharide in protection against low-and high-virulence strains of Francisella tularensis | |
| Flashner et al. | Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates | |
| Gantois et al. | Oral immunisation of laying hens with the live vaccine strains of TAD Salmonella vac® E and TAD Salmonella vac® T reduces internal egg contamination with Salmonella Enteritidis | |
| Kenney et al. | Induction of protective immunity against lethal anthrax challenge with a patch | |
| Bennett-Guerrero et al. | Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine | |
| Jahangiri et al. | Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model | |
| Walker et al. | Vaccines for protecting infants from bacterial causes of diarrheal disease | |
| Hoover et al. | Protection of mice against brucellosis by vaccination with Brucella melitensis WR201 (16MΔ purEK) | |
| Wedlock et al. | Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis | |
| Weiss et al. | Characterization of human bactericidal antibodies to Bordetella pertussis | |
| Dabo et al. | Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice | |
| Ferrieri | Surface-localized protein antigens of group B streptococci | |
| Nygren et al. | Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae | |
| Bhattacharjee et al. | Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine | |
| Subramaniam et al. | A multivalent Mannheimia-Bibersteinia vaccine protects bighorn sheep against Mannheimia haemolytica challenge | |
| Madetoja et al. | Efficacy of injection vaccines against Flavobacterium psychrophilum in rainbow trout, Oncorhynchus mykiss (Walbaum) | |
| Tarique et al. | Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice | |
| Blanco et al. | A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum |